Breakthrough Opioid Use Disorder (OUD) Asset Sale

Final LOI Due TAEUS is managing the complete 100% asset divestiture of the Computerized Oral Prescription Administration System (COPA™) on behalf of Berkshire Biomedical Corporation. Designed to revolutionize treatment in sensitive areas like Opioid Use Disorder (OUD) and controlled drug administration, COPA™ represents a turnkey opportunity to acquire a fully validated, highly secure digital health…

Read More

Intellectual Capital Financing

The most valuable asset of any corporation is its Intellectual Capital (IC).  Unfortunately, no banks, the US Small Business Administration (SBA), or other institutions in the United States will allow IC as collateral for loans. Fortunately, that is not the case in Europe and other places around the world. IC, properly defined, includes not only…

Read More

TAEUS & Microsoft Beget PatentBooks

TAEUS has had a long and colorful history with Microsoft. For nearly four decades, beginning in the early 1990s, TAEUS has investigated Microsoft for patent infringement. In fact, the TAEUS history with Microsoft was PatentBooks genesis. Unisys, via its Burroughs acquisition, developed the Lempel, Ziv, Welch (LZW) patented technology to deal with submarine sonar reports.…

Read More

Where We’ve Been and Where We’re Going

TAEUS Corporation is the world’s first engineering company dedicated to patent licensing, formed originally in July 1992. TAEUS grew organically, helping AT&T identify the best patents obtained in its 1992 NCR purchase. TAEUS served not only AT&T, but all its daughter companies, including Lucent, Avaya, and LSI, for the next two decades. In 1994, TAEUS…

Read More

Global Footprint

TAEUS opened TAEUS Europe, Ltd., its first international subsidiary, in 1996 in London, investigating Microsoft for antitrust on behalf of the European Commission, illustrating how the instructions Microsoft provided to users did not reflect how the Windows® operating system and Internet Explorer® actually worked. The European Commission’s €9M contract with TAEUS Europe, Ltd. yielded a…

Read More

COVID-19 Effects on TAEUS

The entire world, including TAEUS, was affected by the onset of COVID-19 in various ways that differ from one company to another. Many companies had to adapt to working remotely. TAEUS has been working remotely as a specialized team since its founding in 1992! This advantage allowed TAEUS to continue working while other companies had…

Read More

Market Changes

Many patent owners resort to patent brokerage services because they either don’t utilize their patents, or they lack the financial resources to litigate. TAEUS Corporation has helped patent owners monetize their patents since 1992. The patent sale market has gone dry recently. In 2020, the actual patent sales by market year of sale dropped to…

Read More